早期 NSCLC 和新辅助免疫疗法：围手术期使用 pembrolizumab 可提高生存率

{"title":"早期 NSCLC 和新辅助免疫疗法：围手术期使用 pembrolizumab 可提高生存率","authors":"Christine Willen","doi":"10.3238/persesmo.2023.12.01.02","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":11196,"journal":{"name":"Deutsches Ärzteblatt Online","volume":"5 4p2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Frühes NSCLC und neoadjuvante Immuntherapie: Überlebensvorteile mit Pembrolizumab perioperativ\",\"authors\":\"Christine Willen\",\"doi\":\"10.3238/persesmo.2023.12.01.02\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":11196,\"journal\":{\"name\":\"Deutsches Ärzteblatt Online\",\"volume\":\"5 4p2\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Deutsches Ärzteblatt Online\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3238/persesmo.2023.12.01.02\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Deutsches Ärzteblatt Online","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3238/persesmo.2023.12.01.02","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}